-
Document de presse | 2021.06.07
Cells undergoing cell death protect their neighbors to maintain tissue integrity
To enable tissue renewal, human tissues constantly eliminate millions of cells, without jeopardizing tissue integrity, form and connectivity. The mechanisms involved in maintaining this integrity remain unknown. Scientists from the Institut Pasteur and the CNRS today revealed a new process which allows eliminated cells to temporarily protect their neighbors from cell death, thereby maintaining...
-
News | 2020.12.01
AVATAR MEDICAL, a visualization platform to facilitate preparations for complex surgical procedure
AVATAR MEDICAL uses virtual and augmented reality to offer surgeons an immersive, interactive preoperative visualization of 3D medical images of patients obtained with MRI or CT scans.The solution gives physicians the opportunity to view organs, blood vessels and tumors and to prepare for complex medical procedures by navigating effortlessly through all the data, with no pre-processing required....
-
News | 2021.06.01
Tiger mosquito in France: 64 départements on red alert
French health authorities updated their map showing the spread of the tiger mosquito in France. On 1st of January 2021, 64 of the country's départements on "red alert", six more than on 1st of January 2020. Present in France since 2004, the Aedes albopictus mosquito is originally from Asia and is the vector for diseases such as dengue, chikungunya and Zika.In 2021, the tiger mosquito (...
-
Article | 2021.06.24
"HR Excellence in Research" Accreditation
In December 2021, the Institut Pasteur gained the HR Excellence in Research Award from the European Commission and has embarked on a process of continuous improvement regarding recruitment and working conditions for scientists, while strengthening its attractiveness at the international level.
-
Article | 2021.06.24
Legal notice
This information concerns all the sites and subdomains of the Institut Pasteur website. 1. EditorInstitut Pasteur, a recognized public-interest foundation SIREN 775 684 897 25-28 rue du Dr Roux 75724 Paris Cedex 15 - France Phone. : +33 1 45 68 80 00 Publication Director Stewart Cole, Director General of the Institut Pasteur.Editorial managers Hervé...
-
Article | 2021.06.24
Pasteurians and Institut Pasteur alumni Network
The Institut Pasteur gathers its community, Pasteurians and Alumni, with an international network aimed at all past and present Institut Pasteur staff from Paris or any of the members of the Pasteur Network.
-
Document de presse | 2021.06.22
Drug repurposing to counter COVID-19: antiviral activity may be induced by phospholipidosis
Over the past 16 months and against the backdrop of the COVID-19 health crisis, thousands of drugs have been tested with a view to repurpose them to tackle SARS-CoV-2. Many of these drugs have demonstrated potential antiviral activity (23 compounds including hydroxychloroquine, azithromycin, amiodarone and 4 others tested in clinical trials). Given this high number of potential treatments, the...
-
Fiche maladie | 2021.05.11
Parkinson
Parkinson’s disease is a degenerative disorder affecting almost 200,000 people in France. It is the second leading cause of motor disability in adults after stroke and is characterized by the gradual loss of certain neurons in the brain. Although current treatments may alleviate symptoms, they are incapable of slowing disease progression.
-
Document de presse | 2021.06.29
Neonatal meningitis: the immaturity of microbiota and epithelial barriers implicated
Meningitis is associated with high mortality and frequently causes severe sequelae. Newborn infants are particularly susceptible to this type of infection; they develop meningitis 30 times more often than the general population. Group B streptococcus (GBS) bacteria are the most common cause of neonatal meningitis, but they are rarely responsible for disease in adults. Scientists from the Institut...
-
Document de presse | 2021.07.01
Modelling study of benefits and risks associated with the COVID-19 vaccine Vaxzevria
On April 7, 2021, the European Medical Agency (EMA) concluded that thrombosis in combination with thrombocytopenia has been identified as a likely adverse event following vaccination with the COVID-19 vaccine Vaxzevria. Researchers from the Mathematical Modelling of Infectious Diseases Unit at the Institut Pasteur used a mathematical model to assess its benefits and risks in...
